Rocket Pharmaceuticals, Inc.RCKTNASDAQ

Revenue (LTM)

Net Income (LTM)

$-223M

+13.8% YoY

Free Cash Flow

$-190M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-11
Operating Income	-167	-224↓34.1%	-260↓15.7%	-273↓5.2%	-229↑16.4%
Net Income	-169	-222↓31.2%	-246↓10.7%	-259↓5.4%	-223↑13.8%
EBITDA	-158	-214↓35.4%	-237↓10.7%	-247↓4.6%	-210↑15.1%
EPS Diluted	-2.68	-3.26↓21.6%	-2.92↑10.4%	-2.73↑6.5%	-2.01↑26.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	233	141↓39.6%	56↓60.2%	164↑192.7%	78↓52.6%
Total Current Assets	392	364↓7.1%	378↑3.9%	378↓0.0%	193↓49.0%
Total Assets	497	552↑11.0%	566↑2.6%	528↓6.8%	330↓37.4%
Total Current Liabilities	22	39↑76.7%	49↑23.8%	41↓16.1%	30↓25.8%
Total Liabilities	42	62↑46.9%	74↑18.7%	64↓12.6%	53↓17.4%
Total Equity	455	490↑7.7%	493↑0.6%	463↓6.0%	277↓40.2%
Total Debt	23	23↑1.2%	25↑9.5%	25↑1.8%	25↓2.4%
Net Debt	-210	-118↑44.0%	-31↑73.8%	-138↓347.6%	-53↑61.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-121	-178↓47.0%	-195↓9.4%	-210↓7.6%	-190↑9.4%
Capital Expenditure	-8	-9↓11.7%	-16↓91.1%	-6↑64.4%	-0↑92.5%
Free Cash Flow	-129	-187↓44.9%	-211↓13.2%	-216↓2.0%	-190↑11.7%
Stock-Based Comp	29	31↑6.1%	39↑27.1%	44↑11.5%	37↓15.6%
Net Change in Cash	-65	-92↓42.6%	-85↑8.2%	108↑227.4%	-86↓179.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance